Constriction of the fetal ductus arteriosus during prenatal betamethasone therapy

• Tipo: Artigo em Revista Científica Internacional
• Data: 1995

Autores

Azancot Benisty, A (Autor) Outra; Benifla, JL (Autor) Outra; matias, a (Autor) FMUP; De Crepy, A (Autor) Outra; Madelenat, P (Autor) Outra

Revista

Título: Obstetrics and Gynecology

Vol. 85

Páginas: 874-876

ISSN: 0029-7844

Editora: Wolters Kluwer Health

Indexação

Scopus - 33 Citações

Outras Informações

ID Authenticus: P-008-PNC

DOI: 10.1016/0029-7844(94)00445-j

Abstract (EN): Background: Constriction of the fetal ductus arteriosus occurs with maternal indomethacin treatment and has been suggested with corticosteroid therapy as well. Case: Fetal ductal constriction was diagnosed by Doppler echocardiography at 29 weeks' gestation after a third and fourth course of betamethasone was administered to a pregnant woman with placenta previa. Doppler echocardiography showed a patent ductus arteriosus 3 days after the treatment. Conclusion: The risk-benefit ratio of betamethasone should be assessed by large-scale studies when repeated courses or chronic maternal administration of betamethasone are required.

Idioma: Inglês

Tipo (Avaliação Docente): Científica